Raghavendra Tirupathi Govindaraju*
Department of Medicine Keystone Health, Penn State University, School of Medicine, Hershey, USA
*Corresponding Author: Raghavendra Tirupathi Govindaraju, Department of Medicine Keystone Health, Penn State University, School of Medicine, Hershey, USA.
Received: May 26, 2021; Published: September 01, 2021
India is now facing a daunting task of battling the raging COVID-19 surge. It is second wave of infection that has rapidly surpassed its first wave in 2020 in terms of the number of new cases and deaths per day. Rates in India trended down significantly during fall and winter with a complete drop in January. However, March and April had some large public gatherings of thousands of people due to religious activities and political rallies in several states probably leading to dissemination of virus. The country has been recording more than 300,000 cases of COVID-19 per day since April 21, up from 100,000 per day on April 4. These numbers eclipse India's previous highest number of new cases reported in a single day, at 97,860 cases on Sept 16, 2020. Fully opening up with unrestrained crowding, mass gatherings, large scale travel, and lack of personal protective measures such as masks, lack of a concrete national containment, surge and vaccination strategy have all contributed to this very preventable situation. Shortages of Medical oxygen, beds, pharmaceuticals like Remdesivir and Tocilizumab has made the situation even more challenging. Lack of preexisting vaccine procurement contracts are leading to shortages of life saving vaccines at a critical time.
Citation: Raghavendra Tirupathi Govindaraju. “COVID19 Surge in India - What we Know so Far”.Acta Scientific Medical Sciences 5.10 (2021): 01-02.
Copyright: © 2021 Raghavendra Tirupathi Govindaraju. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.